Product Program year 2024 Source: CMS Open Payments

Pressurewire

Device Vascular

PDI 05415067025746

Open in the dashboard

General payments

$186,749

3,741 payments

Research payments

$186,609

17 payments

Through program year 2024, $186,749 in general payments and $186,609 in research payments were reported against Pressurewire (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2024 General $55,263 1,216
2024 Research $13,420 1
2023 General $56,646 1,327
2023 Research $173,189 16
2022 General $74,839 1,198

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $186,749 3,741 payments
Top recipients General payments · program year 2024
  1. Bruce Samuels Cardiovascular Disease · Beverly Hills, CA $8,457 15% · 33 payments
  2. Robert Widmer Interventional Cardiology · Temple, TX $6,000 11% · 1 payment
  3. Joseph Aragon Interventional Cardiology · Santa Barbara, CA $1,143 2% · 14 payments
  4. Afaq Motiwala Interventional Cardiology · Galveston, TX $996 2% · 3 payments
  5. Andre Akhondi Cardiovascular Disease · Thousand Oaks, CA $819 1% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $22,727 41% · 225 practitioners
  2. Cardiovascular Disease Internal Medicine $22,079 40% · 175 practitioners
  3. Internal Medicine $2,470 5% · 29 practitioners
  4. Family Medicine $1,488 3% · 9 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $961 2% · 13 practitioners

The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $24,398 44% · 129 recipients
  2. Texas $8,625 16% · 40 recipients
  3. Michigan $2,899 5% · 36 recipients
  4. New York $2,485 4% · 44 recipients
  5. South Carolina $2,119 4% · 62 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

3,741 general · 17 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record